EVGN — Evogene Ltd.
—
Nasdaq ·
Materials ·
Chemicals ·
CIK 1574565 ·
Last close
$0.47
Market Cap
$5.69M
52W High
$0.85
52W Low
$0.37
ADV30
2,551,740
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 17,948,000 | 8,511,000 | 9,958,000 |
| Dec 2025 | 314,000 | -1,970,000 | -5,212,000 | -5,309,000 | 20,046,000 | 12,956,000 | 8,071,000 |
| Sep 2025 | 312,000 | 155,000 | -2,724,000 | 3,874,000 | 26,086,000 | 5,626,000 | 8,834,000 |
| Jun 2025 | 884,000 | 748,000 | -3,071,000 | -4,462,000 | 33,926,000 | 8,329,000 | 21,551,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,003,000
Investing CF
$-7,000
Financing CF
$-6,375,000
CapEx
$-136,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.17
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-282,556,000
Inventory
$210,000
Receivables
$1,378,000
ST Investments
$10,332,000
EBIT TTM
$-14,422,000
Pretax Income TTM
$-14,583,000
Interest Exp TTM
$161,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,844,000
EBITDA
$-13,334,000
Free Cash Flow
$-12,204,750
Enterprise Value
$4,416,412
Total Cash
$13,054,000
Total Debt
$2,031,000
Shares Out
12,104,457
Trailing EPS
$-2.04
Book Value
$-0.24
ROE
-171.8%
ROA
-32.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,853,000 | -14,034,000 | -8,485,000 | 20,046,000 | 8,071,000 | — | -13,502,000 |
| Dec 2024 | 5,577,000 | -18,757,000 | -16,485,000 | 39,864,000 | 25,026,000 | — | -19,700,000 |
| Dec 2023 | 2,982,000 | -22,205,000 | -23,879,000 | 51,101,000 | 22,416,000 | — | -21,577,000 |
| Dec 2022 | 1,675,000 | -26,941,000 | -26,638,000 | 56,126,000 | 21,336,000 | — | -23,678,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TANH | TANTECH HOLDINGS LTD | $6.07M | $0.42 | — |
| YCBD | cbdMD, Inc. | $5.32M | $0.51 | — |
| DQWS | DSwiss Inc | $6.41M | $0.03 | — |
| BON | Bon Natural Life Ltd | $6.70M | $1.10 | — |
| GURE | GULF RESOURCES, INC. | $4.65M | $3.02 | — |
News headlines (Yahoo Finance, 1h cache)
Evogene Schedules Second Quarter 2026 Financial Results Release
2026-07-30 11:00 · Yahoo
Evogene and ELEO to develop new oral PCSK9 inhibitors
2026-07-23 10:06 · Yahoo
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
2026-07-22 12:00 · Yahoo
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection
2026-07-21 20:31 · Yahoo
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report
2026-07-21 20:27 · Yahoo
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
2026-07-15 11:30 · Yahoo
Evogene and Tel Aviv University launch drug discovery initiative
2026-07-09 10:07 · Yahoo
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
2026-07-08 11:00 · Yahoo
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization
2026-06-24 12:00 · Yahoo
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
2026-06-09 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.